Yifan Zhou

2.1k total citations · 1 hit paper
47 papers, 860 citations indexed

About

Yifan Zhou is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yifan Zhou has authored 47 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 17 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Yifan Zhou's work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Yifan Zhou is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Yifan Zhou collaborates with scholars based in China, United States and Norway. Yifan Zhou's co-authors include Stephanie S. Watowich, Haiyan S. Li, Long Peng, John Z. H. Zhang, Xiao Liu, Youzhi Zhang, Eugenie S. Kleinerman, Oleksandr Kyrysyuk, Yusra B. Medik and Feng Liu and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yifan Zhou

43 papers receiving 854 citations

Hit Papers

Targeting PD-L2–RGMb overcomes microbiome-related immunot... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifan Zhou China 18 372 327 273 91 87 47 860
Ola H. Negm United Kingdom 18 478 1.3× 163 0.5× 209 0.8× 135 1.5× 85 1.0× 44 892
Peter Blattmann Switzerland 14 550 1.5× 259 0.8× 132 0.5× 62 0.7× 51 0.6× 25 1.0k
Xiaodong Wu China 14 353 0.9× 138 0.4× 133 0.5× 50 0.5× 61 0.7× 57 732
Scott Wadsworth United States 20 545 1.5× 435 1.3× 226 0.8× 186 2.0× 29 0.3× 30 1.3k
Kathryn A. Skelding Australia 19 679 1.8× 197 0.6× 172 0.6× 177 1.9× 69 0.8× 34 1.2k
J. Perry Hall United States 22 1.1k 2.9× 514 1.6× 149 0.5× 153 1.7× 83 1.0× 36 1.7k
Xinhao Zhao China 14 378 1.0× 233 0.7× 76 0.3× 40 0.4× 37 0.4× 19 812
Yun Liang China 17 597 1.6× 597 1.8× 185 0.7× 146 1.6× 44 0.5× 36 1.2k
Christel Goudot France 13 558 1.5× 975 3.0× 425 1.6× 92 1.0× 46 0.5× 21 1.5k
Cesar F. Ortega-Cava Japan 15 434 1.2× 403 1.2× 179 0.7× 141 1.5× 64 0.7× 19 1.1k

Countries citing papers authored by Yifan Zhou

Since Specialization
Citations

This map shows the geographic impact of Yifan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Zhou more than expected).

Fields of papers citing papers by Yifan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Zhou. The network helps show where Yifan Zhou may publish in the future.

Co-authorship network of co-authors of Yifan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yifan Zhou. A scholar is included among the top collaborators of Yifan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifan Zhou. Yifan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jiang, Chuang, et al.. (2024). Role of microvascular invasion in early recurrence of hepatocellular carcinoma after liver resection: A literature review. Asian Journal of Surgery. 47(5). 2138–2143. 17 indexed citations
3.
Zhou, Yifan, et al.. (2024). CD103+ cDC1 Dendritic Cell Vaccine Therapy for Osteosarcoma Lung Metastases. Cancers. 16(19). 3251–3251. 4 indexed citations
4.
Patel, Bhakti, Yifan Zhou, Feiyang Ma, et al.. (2024). STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response. Leukemia. 38(5). 1143–1155. 2 indexed citations
5.
Zhou, Yifan, Jingjing Ma, Lei Zhang, et al.. (2024). Heat-killed Prevotella intermedia promotes the progression of oral squamous cell carcinoma by inhibiting the expression of tumor suppressors and affecting the tumor microenvironment. Experimental Hematology and Oncology. 13(1). 33–33. 10 indexed citations
6.
Park, Joon Seok, Francesca S. Gazzaniga, Meng–Huang Wu, et al.. (2023). Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance. Nature. 617(7960). 377–385. 120 indexed citations breakdown →
7.
Zhou, Yanfeng, et al.. (2023). Chromosome-Level Genome Assembly of Protosalanx chinensis and Response to Air Exposure Stress. Biology. 12(9). 1266–1266. 2 indexed citations
8.
Zhou, Yifan, Laura M. Kahn, Bhakti Patel, et al.. (2022). STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells. The Journal of Immunology. 209(7). 1286–1299. 3 indexed citations
9.
Tang, Xuemei, et al.. (2022). Interaction of Microbiota between Fish and the Environment of an In-Pond Raceway System in a Lake. Microorganisms. 10(6). 1143–1143. 9 indexed citations
11.
Yu, Jiadong, Qixiang Zhao, Xiaoyan Wang, et al.. (2022). Pathogenesis, multi-omics research, and clinical treatment of psoriasis. Journal of Autoimmunity. 133. 102916–102916. 58 indexed citations
12.
Zhou, Yifan, et al.. (2021). STAT3 and IL-10 inhibit interferon signaling in type 1 conventional dendritic cells. The Journal of Immunology. 206(1_Supplement). 97.13–97.13.
13.
Tang, Yijing, Dong Zhang, Yonglan Liu, et al.. (2021). A new strategy to reconcile amyloid cross‐seeding and amyloid prevention in a binary system of α‐synuclein fragmental peptide and hIAPP. Protein Science. 31(2). 485–497. 12 indexed citations
14.
Zhou, Yifan, Haiyan S. Li, Bhakti Patel, et al.. (2020). STAT3 Inhibits CD103+ cDC1 Vaccine Efficacy in Murine Breast Cancer. Cancers. 12(1). 128–128. 16 indexed citations
15.
Zhou, Yifan, Oleksandr Kyrysyuk, Yusra B. Medik, et al.. (2020). Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells. Journal for ImmunoTherapy of Cancer. 8(1). e000474–e000474. 84 indexed citations
16.
Liu, Jinxia, Hui Xu, Xuening Zhang, et al.. (2018). ARP3 promotes tumor metastasis and predicts a poor prognosis in hepatocellular carcinoma. Pathology - Research and Practice. 214(9). 1356–1361. 6 indexed citations
17.
Veruki, Margaret Lin, Yifan Zhou, Áurea Castilho, Catherine W. Morgans, & Espen Hartveit. (2018). Extrasynaptic NMDA Receptors on Rod Pathway Amacrine Cells: Molecular Composition, Activation, and Signaling. Journal of Neuroscience. 39(4). 627–650. 13 indexed citations
18.
Zhang, Youzi, Xiao Liu, Yifan Zhou, & John Z. H. Zhang. (2017). Calculation of PARP1-ligand binding free energy using alanine scanning and interaction entropy method. Scientia Sinica Chimica. 48(2). 204–209.
19.
Zhou, Yifan, Jianfeng Wu, Chunxiao Liu, et al.. (2016). p38α has an important role in antigen cross-presentation by dendritic cells. Cellular and Molecular Immunology. 15(3). 246–259. 18 indexed citations
20.
Zhou, Yifan, et al.. (2015). Functional NMDA receptors are expressed by both AII and A17 amacrine cells in the rod pathway of the mammalian retina. Journal of Neurophysiology. 115(1). 389–403. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026